AGP Picks
View all

Williams Hart & Boundas partner wins AAJ spotlight award

4 hours ago
By AI, Created 09:41 UTC, Sep 01, 2026, AGP -

Sejal Brahmbhatt, a Houston partner at Williams Hart & Boundas, received the 2026 Dawn Barrios Memorial Spotlight Award from the Women Trial Lawyers Caucus of the American Association for Justice. The honor highlights her work in pharmaceutical and medical device mass tort litigation and was presented at the AAJ annual convention in Chicago.

Why it matters: - The award recognizes a Houston trial lawyer whose practice has focused on pharmaceutical and medical device litigation for more than two decades. - The honor also spotlights women lawyers taking leading roles in national mass tort cases.

What happened: - Sejal Brahmbhatt, a partner at Williams Hart & Boundas, received the 2026 Dawn Barrios Memorial Spotlight Award from the Women Trial Lawyers Caucus of the American Association for Justice. - The Caucus presented the award at the AAJ’s 2026 Annual Convention in Chicago. - Williams Hart & Boundas announced the honor on Aug. 12, 2026. - The award recognized Brahmbhatt’s work in the mass tort arena.

The details: - The Women Trial Lawyers Caucus created the award in 2024 to honor Dawn M. Barrios, a longtime trial lawyer known for service to the legal community. - The Caucus operates within the American Association for Justice, a national organization of plaintiffs’ trial attorneys. - Brahmbhatt has spent more than two decades at Williams Hart & Boundas, where she has handled litigations from inception through trial and resolution. - Brahmbhatt joined the Houston firm in 2003. - Her practice has centered on claims involving pharmaceuticals and medical devices. - Brahmbhatt has served in plaintiffs’ leadership roles in national mass tort proceedings. - Her work has also included representing women pursuing claims against rideshare companies. - She was named to Texas Super Lawyers Rising Stars in 2013 and 2014. - She has been named a Texas Super Lawyer every year since 2021. - Brahmbhatt also speaks at national conferences on pharmaceutical litigation and mass tort strategy. - In a statement, Brahmbhatt called Dawn Barrios a trailblazer, a wonderful human being and a dedicated trial lawyer. - Brahmbhatt said she hopes to continue representing clients to the standard Barrios set.

Between the lines: - The recognition underscores how mass tort and product liability work can elevate attorneys into national leadership roles. - The award also connects Brahmbhatt’s career to a broader plaintiffs’ bar tradition centered on trial advocacy and legal community service.

What's next: - Brahmbhatt is likely to continue handling pharmaceutical, medical device and other mass tort matters for Williams Hart & Boundas. - Her profile may grow further through leadership roles, speaking appearances and future trial work. - Williams Hart & Boundas continues to promote its trial practice across injury and mass tort cases.

The bottom line: - The AAJ honor places Brahmbhatt among a small group of trial lawyers recognized for leadership, client advocacy and impact in mass tort litigation.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Illinois Government Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Illinois Government Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.